Inhibition/NN
of/IN
NF-kappa/NN
B/NN
activation/NN
in/FW
vitro/FW
and/CC
in/FW
vivo/FW
:/:
role/NN
of/IN
26S/NN
proteasome/NN
./.

It/PRP
is/VBZ
becoming/VBG
increasingly/RB
apparent/JJ
that/IN
NF-kappa/NN
B/NN
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
regulating/VBG
the/DT
inflammatory/JJ
response/NN
./.
=====
Data/NNS
obtained/VBN
from/IN
studies/NNS
in/IN
our/PRP$
laboratories/NNS
demonstrate/VBP
that/IN
the/DT
proteasome/NN
plays/VBZ
an/DT
important/JJ
role/NN
in/IN
the/DT
inflammatory/JJ
cascade/NN
by/IN
regulating/VBG
the/DT
activation/NN
of/IN
NF-kappa/NN
B/NN
./.
=====
Indeed/RB
,/,
the/DT
availability/NN
of/IN
selective/JJ
and/CC
orally/RB
active/JJ
proteasome/NN
inhibitors/NNS
should/MD
prove/VB
useful/JJ
in/IN
delineating/VBG
the/DT
roles/NNS
of/IN
the/DT
proteasome/NN
and/CC
NF-kappa/NN
B/NN
in/IN
other/JJ
pathophysiological/JJ
conditions/NNS
such/JJ
as/IN
cancer/NN
and/CC
heart/NN
disease/NN
./.